npc 12626 has been researched along with oxidopamine in 1 studies
Studies (npc 12626) | Trials (npc 12626) | Recent Studies (post-2010) (npc 12626) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
---|---|---|---|---|---|
55 | 0 | 0 | 8,630 | 6 | 2,407 |
Protein | Taxonomy | npc 12626 (IC50) | oxidopamine (IC50) |
---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abreu, M; Ferkany, J; French, ED; Levenson, S | 1 |
1 other study(ies) available for npc 12626 and oxidopamine
Article | Year |
---|---|
Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
Topics: Amino Acids; Amphetamine; Animals; Behavior, Animal; Dopamine; Electrophysiology; Limbic System; Male; Mesencephalon; Motor Activity; N-Methylaspartate; Neurons; Nucleus Accumbens; Oxidopamine; Phencyclidine; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |